Articles that mention AstraZeneca -BoardProspects

AstraZeneca

0 Comments Leave a Comment

1-15 of 31 1 2 »
1. Mentioned In 31 Articles
2. Astra Plots Post-Covid Future With $39 Billion Alexion Deal
  
  Explore msn.com Dec 12 2020 BoardNews
  
  ... rare diseases. In the sale to AstraZeneca, holders of each Alexion share will receive $60 in cash and 2.1243 AstraZeneca American depositary shares, the U.K. company said in a press release Saturday. The drugmaker will ...
  Read Full Article
  
  Comment
  
  Mentions: Management Goldman Sachs CFO
3. 20 Highest-Paid Biopharma CEOs
  
  Explore Pharma News Sep 18 2020 BoardNews
  
  ...old for this year's top-paid CEOs list. A collection of Big Pharma chiefs stay off that list year after year. AstraZeneca's ($AZN) Pascal Soriot, for instance. GlaxoSmithKline's ($GSK) Andrew Witty. And this year, both J...
  Read Full Article
  
  Comment
  
  Mentions: Twitter stock options Vertex
4. Gilead Reaches $21 Billion Deal for Immunomedics
  
  Explore MarketWatch Sep 13 2020 BoardNews
  
  ...t can help patients, and the therapies can command high prices. As a result, the biggest drugmakers including AstraZeneca PLC, Pfizer Inc. and GlaxoSmithKline PLC have moved to establish beachheads in cancer treatment, c...
  Read Full Article
  
  Comment
  
  Mentions: acquisition stake Gilead Sciences
5. NeoGenomics (NEO) Adds Rachel A. Stahler and Michael A. Kelly to Board
  
  Explore StreetInsider.com Jul 20 2020 BoardMoves
  
  ...ecutive team as Executive Vice President of Human Resources and Corporate Affairs from 2007 to 2014. Prior to AstraZeneca, Ms. Tetrault practiced healthcare and corporate law at Choate, Hall and Stewart in Boston. Ms. Te...
  Read Full Article
  
  Comment
  
  Mentions: Human Resources Leadership Independent Director
6. Sandra Horning, MD To Join Moderna's Board of Directors
  
  Explore Digital Journal Feb 3 2020 BoardMoves
  
  ...s. Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. (Nasdaq: AZN) and Merck, Inc. (Nasdaq: MRK), as well as the Defense Advanced Research Projec...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Annual Meeting Nasdaq
7. Model N Welcomes Kimberly DeCarlis as New Board Member
  
  Explore businesswire.com Jan 15 2020 BoardMoves
  
  ...logy, semiconductor, and high-tech manufacturing across more than 120 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com....
  Read Full Article
  
  Comment
  
  Mentions: Chief Marketing Officer NYSE Stanford University
8. François Nader, MD, Joins Moderna's Board of Directors
  
  Explore businesswire.com Dec 10 2019 BoardMoves
  
  ...s. Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. (NASDAQ: AZN) and Merck, Inc. (NASDAQ: MRK), as well as the Defense Advanced Research Projec...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Leadership Sanofi
9. Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments
  
  Explore businesswire.com Sep 27 2019 BoardMoves
  
  ... OTEZLA® is a registered trademark of Celgene Corporation. PRILOSEC® and NEXIUM® are registered trademarks of AstraZeneca. David Socks info@phathompharma.com +1-650-325-5156 David Socks info@phathompharma.com +1-650-325-...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Succession General Motors
10. AstraZeneca Plots Search for Next Chairman
  
  Explore Yahoo! UK & Ireland Finance Jun 3 2019 BoardNews
  
  ... stages of planning to seek an eventual replacement for Leif Johansson, who has chaired AZ for seven years... AstraZeneca (AZ), the FTSE-100 pharmaceuticals group, is preparing a search for the successor to the chairman ...
  Read Full Article
  
  Comment
  
  Mentions: Takeover Bid Succession CFO
11. Exploring Employee Activism: Why This Stakeholder Group Can No Longer Be Ignored
  
  Explore greenbiz.com May 27 2019 BoardBlogs
  
  ...ore values can bring a powerful competitive advantage. Jim Massey, global vice president of sustainability at AstraZeneca, told me he sees a pressing need for greater inclusion: "The societal challenges we are facing tod...
  Read Full Article
  
  Comment
  
  Mentions: Management Amazon ISS
12. Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, to Board of Directors
  
  Explore gurufocus.com May 13 2019 BoardMoves
  
  ...ne for more than a decade and has more than two decades of regulatory leadership experience. Prior to joining AstraZeneca in April 2018, Dr. Chowdhury served at the FDA for 21 years, where he held numerous leadership rol...
  Read Full Article
  
  Comment
  
  Mentions: Canada AstraZeneca Annual Report
13. Could Proxy Advisers Sway Investors to Vote ‘No’ on BMS-Celgene Merger?
  
  Explore Pharma News Mar 21 2019 BoardBlogs
  
  ...rms like ISS certainly can’t be discounted when it comes to swaying shareholder opinion. Last year, ISS urged AstraZeneca shareholders to vote against the company’s planned bonus for CEO Pascal Soriot. That was enough to...
  Read Full Article
  
  Comment
  
  Mentions: Management Credit Suisse ISS
14. Lilly CEO David Ricks Snags $17.2M Pay Package for 2018, a 9% Hike
  
  Explore Pharma News Mar 13 2019 BoardNews
  
  ...hrough some problems of its own, paid its helmsman Olivier Brandicourt $8.2 million last year, a 25% decline. AstraZeneca CEO Pascal Soriot's pay climbed to nearly $15 million, and new Novartis helmsman Vas Narasimhan ea...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi stock options David Ricks
15. AstraZeneca Pays CEO Soriot Nearly $15M After 2018's Return to Growth. Will Investors Push Back?
  
  Explore Pharma News Mar 5 2019 BoardNews
  
  ...AstraZeneca CEO Pascal Soriot earned 11.36 million in total pay last year, a 9% increase over 2017. (AstraZeneca) In the past, AstraZeneca's investors have hit out at the company for executive compensation they ...
  Read Full Article
  
  Comment
  
  Mentions: stock options AstraZeneca Pascal Soriot
16. AVEO Oncology Announces Appointment of Gregory T. Mayes to its Board of Directors
  
  Explore businesswire.com Feb 26 2019 BoardMoves
  
  ...range of legal services in connection with the development and commercialization of five approved products in AstraZeneca's oncology portfolio. Mayes is a cum laude graduate of Syracuse University where he was recognized...
  Read Full Article
  
  Comment
  
  Mentions: Management General Counsel AstraZeneca
17. 1-15 of 31 1 2 »